Ask AI
IL-13 Inhibition for Atopic Dermatitis

CE / CME

Addressing the Burden of Atopic Dermatitis: IL-13 Inhibition for Moderate to Severe Disease

Physician Assistants/Physician Associates: 0.25 AAPA Category 1 CME credit

ABIM MOC: maximum of 0.25 Medical Knowledge MOC point

Pharmacists: 0.25 contact hour (0.025 CEUs)

Nurse Practitioners/Nurses: 0.25 Nursing contact hour

Physicians: maximum of 0.25 AMA PRA Category 1 Credit

Released: August 28, 2025

Expiration: August 27, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following is a red flag that suggests a patient may have a serious form of secondary headache requiring immediate investigation?

How Confident are you in your answer?
2.

Preventive treatment for episodic migraine headaches should be offered when your patient:

How Confident are you in your answer?
3.

Monoclonal antibody CGRP inhibitors are FDA approved for:

How Confident are you in your answer?
4.

Which of Anna’s characteristics suggest migraine is the most likely diagnosis?

5.

Which of the following agents would be the best choice for prevention of Anna’s episodic migraine?

6.

Three months later, Anna’s episodic migraine still causes unacceptable impairment to her lifestyle. Which of the following would be an appropriate next step for migraine prevention? 

7.
Which of the following approaches would be appropriate to manage Bill's returning arthralgias?
How Confident are you in your answer?
8.
Check all elements that are required on a Refill Request for shipment.
How Confident are you in your answer?